News for Exagen Inc Registered Shs

Markets Insider Automation 12h

Here's what Wall Street expects from Exagen's earnings

Markets Insider Automation 13h

Exagen Inc Registered Shs hosts conference call for investors

Benzinga 3d

Exagen Earnings Preview

reNEWS 69d

Exagen submits plan for 500MW battery site

Seeking Alpha 102d

Pharvaris, Incannex top healthcare gainers; Eiger, Relmada among losers

Benzinga 112d

Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday

RTTNews 115d

Pre-market Movers: SLS, BLDE, PTIC, TNYA, MANU…

Benzinga 115d

Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket

Benzinga 115d

Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday

Benzinga 123d

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday

Benzinga 123d

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session

Seeking Alpha 123d

CWCO, SLNO and SGLY among mid-day movers

Seeking Alpha 124d

InMed, AirSculpt top healthcare gainers; BrainsWay, Brookdale among losers

Benzinga 124d

Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday

Benzinga 124d

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session

Seeking Alpha 124d

TUSK, ZH and CHRA among mid-day movers

Seeking Alpha 124d

Exagen stock climbs 47% on raised guidance, stronger-than-expected results

Benzinga 125d

Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90%

Zacks 125d

Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates

GlobeNewswire 125d

Exagen Inc. Reports Third Quarter 2022 Results

Seeking Alpha 125d

Exagen GAAP EPS, revenue beats, FY22 guidance raised

Markets Insider Automation 127d

Here's what to expect from Exagen's earnings report

GlobeNewswire 131d

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

GlobeNewswire 139d

Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022

TipRanks 152d

Analysts Are Bullish on Top Healthcare Stocks: Minerva Neurosciences (NERV), Exagen (XGN)

GlobeNewswire 154d

Exagen Announces Appointment of John Aballi as CEO

Seeking Alpha 154d

Exagen appoints John Aballi as CEO

GlobeNewswire 167d

Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer

Benzinga 174d

Short Interest Sector Focus: Healthcare Sector

GlobeNewswire 180d

Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting

GlobeNewswire 199d

Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients

Benzinga 201d

Short Interest Sector Focus: Healthcare Sector

Benzinga 224d

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday

Benzinga 226d

Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session

MotleyFool 226d

Exagen Inc. (XGN) Q2 2022 Earnings Call Transcript

Seeking Alpha 226d

RHE, HIHO and FEDU among mid-day movers

Zacks 227d

Exagen Inc. (XGN) Reports Q2 Loss, Lags Revenue Estimates

GlobeNewswire 227d

Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA

GlobeNewswire 227d

Exagen Inc. Reports Second Quarter 2022 Results

Seeking Alpha 227d

Exagen GAAP EPS of -$0.78 misses by $0.21, revenue of $8.96M misses by $3.07M

Markets Insider Automation 229d

Here's what to expect from Exagen's earnings

GlobeNewswire 237d

Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

GlobeNewswire 241d

Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022

GlobeNewswire 258d

Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility

GlobeNewswire 284d

Exagen Inc. Expands Coverage with MediNcrease

Seeking Alpha 284d

Exagen expands coverage for its AVISE tests with MediNcrease provider network

GlobeNewswire 297d

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

GlobeNewswire 307d

Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus

MotleyFool 312d

Exagen Inc. (XGN) Q1 2022 Earnings Call Transcript

Zacks 312d

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates